Rift Valley Fever Innovation Lab: Rift Valley Fever neutralizing antibody titers of  goats (Capra aegagrus ) vaccinated with 1×105.0 PFU/ml of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates and revaccinated with 1 x 104.0 PFU/ml of MP-12
Vaccination of domestic ruminants is considered to be an effective strategy for protecting these animals against Rift Valley fever (RVF), but available vaccines have limitations. Therefore, the aim of this study was to determine the safety and immunogenicity of RVF virus (RVFV) mutagenesis passage 12 (MP-12) and …